resTORbio, Inc. (NASDAQ:TORC) has a beta value of 2.6 and has seen 989,307 shares traded in the last trading session. The company, currently valued at $79.45 Million, closed the last trade at $2.18 per share which meant it lost $0 on the day or 1.87% during that session. The TORC stock price is -448.62% off its 52-week high price of $11.96 and 60.55% above the 52-week low of $0.86. If we look at the company’s 10-day average daily trading volume, we find that it stood at 965.55 Million shares traded. The 3-month trading volume is 1.36 Million shares.
The consensus among analysts is that resTORbio, Inc. (TORC) is a Buy stock at the moment, with a recommendation rating of 2.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.25.
resTORbio, Inc. (NASDAQ:TORC) trade information
Sporting 1.87% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jun 23 when the TORC stock price touched $2.42-9 or saw a rise of 9.92%. Year-to-date, resTORbio, Inc. shares have moved 46.31%, while the 5-day performance has seen it change 3.81%. Over the past 30 days, the shares of resTORbio, Inc. (NASDAQ:TORC) have changed -4.39%. Short interest in the company has seen 744.67 Million shares shorted with days to cover at 547.55.
Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 83.49% from current levels. The projected low price target is $4 while the price target rests at a high of $4. In that case, then, we find that the current price level is +83.49% off the targeted high while a plunge would see the stock lose 83.49% from current levels.
resTORbio, Inc. (TORC) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest -69.5% while over the next 5 years, the company’s earnings are expected to increase by 29.1%.
resTORbio, Inc. (NASDAQ:TORC)’s Major holders
Insiders own 15.95% of the company shares, while shares held by institutions stand at 39.51% with a share float percentage of 47.01%. Investors are also buoyed by the number of investors in a company, with resTORbio, Inc. having a total of 90 institutions that hold shares in the company. The top two institutional holders are Orbimed Advisors LLC. with over 4.83 Million shares worth more than $4.98 Million. As of March 30, 2020, Orbimed Advisors LLC. held 13.25% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 1.58 Million shares as of March 30, 2020. The firm’s total holdings are worth over $1.63 Million and represent 4.34% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of March 30, 2020, the former fund manager holds about 1.35% shares in the company for having 491365 shares of worth $506.11 Thousand while later fund manager owns 334.67 Thousand shares of worth $344.71 Thousand as of March 30, 2020, which makes it owner of about 0.92% of company’s outstanding stock.